TERBICIP TABS

About

TERBICIP TABS contain Terbinafine, an antifungal medication belonging to the allylamine class. It works by inhibiting squalene epoxidase, an enzyme crucial for fungal ergosterol synthesis. This inhibition leads to an accumulation of squalene within the fungal cell, which is toxic and ultimately causes fungal cell death. Terbinafine is highly effective against dermatophytes, the fungi responsible for most skin, hair, and nail infections, including tinea pedis, tinea cruris, and onychomycosis. Its fungicidal action makes it a potent treatment for various superficial and systemic fungal infections. It achieves high cure rates, particularly in onychomycosis, due to its ability to concentrate in the nail bed, providing sustained therapeutic levels. This targeted mechanism ensures effective eradication of fungal pathogens, leading to significant clinical improvement and preventing recurrence.

Uses

• Onychomycosis (fungal nail infections)
• Tinea pedis (athlete's foot)
• Tinea cruris (jock itch)
• Tinea corporis (ringworm)

Directions For Use

Take orally once daily, usually for several weeks to months depending on the infection type and severity. Can be taken with or without food.

Benefits

• Highly effective against dermatophyte infections.
• Achieves high cure rates for nail infections.
• Fungicidal action, killing the fungi.
• Relieves itching and discomfort quickly.
• Prevents recurrence of fungal infections.
• Generally well-tolerated.

Side Effects

• Headache
• Nausea
• Diarrhea
• Abdominal pain
• Indigestion
• Rash
• Itching
• Taste disturbance (dysgeusia)
• Joint pain
• Muscle pain
• Liver enzyme elevation
• Fatigue

Safety Measures

• Alcohol - Avoid or limit alcohol due to increased risk of liver damage, as Terbinafine can also affect the liver.
• Pregnancy - Not recommended unless clearly necessary; consult a doctor as limited human data exists.
• Breastfeeding - Not recommended; Terbinafine passes into breast milk and may harm the infant.
• Liver - Contraindicated in chronic or active liver disease; monitor liver function during treatment.
• Kidney - Use with caution in moderate to severe renal impairment; dose reduction may be required.
• Lung - Generally no specific lung considerations; safe for use in patients with lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.